Sulfuric Acid

Sulfuric Acid

SCHEMBL665483

O=S(=O)([O-])[O-].O=S(=O)([O-])[O-].O=S(=O)([O-])[O-].[Eu+3].[Eu+3]

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.46
ALDH1A1 P00352 1/20 0.46
TSHR P16473 1/20 0.46
KMT2A Q03164 1/20 0.46
TP53 P04637 1/20 0.40
CA5A P35218 2/20 0.30
CA5B Q9Y2D0 2/20 0.30
KDM4E B2RXH2 1/20 0.30
CYP3A4 P08684 1/20 0.30
CA1 P00915 1/20 0.30
CA2 P00918 1/20 0.30
CA4 P22748 1/20 0.30
CA6 P23280 1/20 0.30
CA7 P43166 1/20 0.30
CA9 Q16790 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sulfuric Acid SCHEMBL28930245 0.94 MEN1 (0.42) MEN1ALDH1A1TSHRKMT2ATP53
Sulfuric Acid SCHEMBL9653125 0.94 MEN1 (0.42) MEN1ALDH1A1TSHRKMT2ATP53
Sulfuric Acid SCHEMBL8850058 0.94 MEN1 (0.42) MEN1ALDH1A1TSHRKMT2ATP53
Sulfuric Acid SCHEMBL20838225 0.94 MEN1 (0.42) MEN1ALDH1A1TSHRKMT2ATP53
Sulfuric Acid SCHEMBL22203986 0.94 MEN1 (0.42) MEN1ALDH1A1TSHRKMT2ATP53
Sulfuric Acid SCHEMBL28574698 0.94 MEN1 (0.42) MEN1ALDH1A1TSHRKMT2ATP53
Sulfuric Acid SCHEMBL28947763 0.94 MEN1 (0.42) MEN1ALDH1A1TSHRKMT2ATP53
Sulfuric Acid SCHEMBL187222 0.93 MEN1 (0.50) MEN1ALDH1A1TSHRKMT2ATP53
Sulfuric Acid SCHEMBL7452194 0.86 MEN1 (0.46) MEN1ALDH1A1TSHRKMT2ATP53
Sulfuric Acid SCHEMBL1447513 0.86 MEN1 (0.46) MEN1ALDH1A1TSHRKMT2ATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 856 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12545810-B2 Magnetic polishing slurry and method for polishing a workpiece TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY LTD. (TW) 2026-02-10 US claimed
CN-119965313-A Preparation method of water-based iron-europium flow battery and electrolyte 北京化工大学 2025-05-09 CN claimed
CN-119551727-A Preparation method and application of metal-doped perovskite manganese dioxide 苏州城市学院 2025-03-04 CN claimed
CN-119542392-A Carbon-coated europium-doped sodium ferric sulfate positive electrode material, preparation method thereof, sodium ion battery and electric equipment 贵州为方能源新材料科技有限公司 2025-02-28 CN claimed
CN-119542445-A Topological chiral half-metal catalyst for oxygen electrocatalysis and preparation method and application thereof 中国科学院宁波材料技术与工程研究所 2025-02-28 CN claimed
CN-119490846-A Water-based reagent for quickly spraying and displaying fingerprints 公安部鉴定中心 2025-02-21 CN claimed
CN-119370814-A Preparation of lithium iron phosphate nanospheres 深圳市沃伦特新能源有限公司 2025-01-28 CN claimed
CN-119364997-A ZnO-based nano-doped material, preparation method thereof and QLED device 河南大学 2025-01-24 CN claimed
CN-119324241-A Novel europium cerium flow battery electrolyte and preparation method thereof 北京化工大学 2025-01-17 CN claimed
CN-116333642-B Composite EVA material, adhesive film, preparation method and application of adhesive film, and battery assembly 上海朗亿功能材料有限公司 2025-01-10 CN claimed
EP-0330800-A1 A method for affecting intracellular and extracellular electric and magnetic dipoles SCHERING AKTIENGESELLSCHAFT (DE) 1989-09-06 EP claimed
EP-0330799-A1 A method for the treatment of arthritis and inflammatory joint diseases SCHERING AKTIENGESELLSCHAFT (DE) 1989-09-06 EP claimed
EP-0330801-A1 Ferromagnetic, diamagnetic or paramagnetic particles useful in the diagnosis and treatment of disease SCHERING AKTIENGESELLSCHAFT (DE) 1989-09-06 EP claimed
US-4829984-A Method for the improvement of transplantation techniques and for the preservation of tissue GORDON ROBERT T (US) 1989-05-16 US claimed
US-4813399-A Process for the treatment of neurological or neuromuscular diseases and development GORDON ROBERT T (US) 1989-03-21 US claimed
US-4767611-A KILING CANCER CELLS WITHOUT DAMAGING NORMAL CELLS; METAL CHELATES, COMPLEXES WITH DEXTRAN, PORPHYRINS; ELECTROMAGNETIC ENERGY GORDON ROBERT T (US) 1988-08-30 US claimed
US-4758429-A Method for the treatment of arthritis and inflammatory joint diseases GORDON, DAVID, SKOKIE, ILLINOIS 1988-07-19 US claimed
US-4610241-A Atherosclerosis treatment method GORDON, DAVID, SKOKIE, ILLINOIS 1986-09-09 US claimed
US-4590922-A INTRACELLULARLY LOCALIZING, THEN INDUCTINELY HEATING GORDON, DAVID, SKOKIE, ILLINOIS 1986-05-27 US claimed
US-4126807-A Gas discharge display device containing source of lanthanum series material in dielectric layer of envelope structure OWENS-ILLINOIS, INC. (US) 1978-11-21 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12545810-B2 Magnetic polishing slurry and method for polishing a workpiece CHKB, SMARCE1, SIK2 MEN1 774/4885ALDH1A1 4648/4885TSHR 3036/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.